Wang L - Search Results

1

Time-course analysis of microRNA-induced mesenchymal-to-epithelial transition underscores the complexity of the underlying molecular processes.

Lili LN, Huang AD, Zhang M, Wang L, McDonald LD, Matyunina LV, Satpathy M, McDonald JF. Lili LN, et al. Among authors: wang l. Cancer Lett. 2018 Aug 1;428:184-191. doi: 10.1016/j.canlet.2018.05.001. Epub 2018 May 5. Cancer Lett. 2018. PMID: 29733963 Free article.

2

Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells.

Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF. Chen J, et al. Among authors: wang l. Gynecol Oncol. 2011 Apr;121(1):200-5. doi: 10.1016/j.ygyno.2010.12.339. Epub 2011 Jan 28. Gynecol Oncol. 2011. PMID: 21277012

3

Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF. Wang L, et al. Mol Cell Biochem. 2012 Apr;363(1-2):257-68. doi: 10.1007/s11010-011-1178-6. Epub 2011 Dec 9. Mol Cell Biochem. 2012. PMID: 22160925

4

The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated.

Shahab SW, Matyunina LV, Hill CG, Wang L, Mezencev R, Walker LD, McDonald JF. Shahab SW, et al. Among authors: wang l. BMC Med Genomics. 2012 Aug 1;5:33. doi: 10.1186/1755-8794-5-33. BMC Med Genomics. 2012. PMID: 22853714 Free PMC article.

5

Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells.

Mezencev R, Wang L, Xu W, Kim B, Sulchek TA, Daneker GW, McDonald JF. Mezencev R, et al. Among authors: wang l. Anticancer Drugs. 2013 Jun;24(5):504-18. doi: 10.1097/CAD.0b013e32836009d7. Anticancer Drugs. 2013. PMID: 23511429

6

Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.

Wang L, Mezencev R, Švajdler M, Benigno BB, McDonald JF. Wang L, et al. Gynecol Oncol. 2014 Jul;134(1):96-103. doi: 10.1016/j.ygyno.2014.04.055. Epub 2014 May 4. Gynecol Oncol. 2014. PMID: 24802724

7

Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity.

Satpathy M, Mezencev R, Wang L, McDonald JF. Satpathy M, et al. Among authors: wang l. Sci Rep. 2016 Nov 7;6:36518. doi: 10.1038/srep36518. Sci Rep. 2016. PMID: 27819259 Free PMC article.

8

Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening.

Mezencev R, Wang L, McDonald JF. Mezencev R, et al. Among authors: wang l. J Ovarian Res. 2012 Oct 18;5(1):30. doi: 10.1186/1757-2215-5-30. J Ovarian Res. 2012. PMID: 23078816 Free PMC article.

9

Distinct metabolic responses of an ovarian cancer stem cell line.

Vermeersch KA, Wang L, McDonald JF, Styczynski MP. Vermeersch KA, et al. Among authors: wang l. BMC Syst Biol. 2014 Dec 18;8:134. doi: 10.1186/s12918-014-0134-y. BMC Syst Biol. 2014. PMID: 25518943 Free PMC article.

10

OVCAR-3 spheroid-derived cells display distinct metabolic profiles.

Vermeersch KA, Wang L, Mezencev R, McDonald JF, Styczynski MP. Vermeersch KA, et al. Among authors: wang l. PLoS One. 2015 Feb 17;10(2):e0118262. doi: 10.1371/journal.pone.0118262. eCollection 2015. PLoS One. 2015. PMID: 25688563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,948 results

Search Page

Filters